7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2018-03-31 2017-06-30 2016-06-30 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-09-30 2012-06-30 2011-09-30 2011-06-30 2011-03-31 2010-09-30 2010-06-30 2010-03-31 2009-09-30 2008-09-30 2008-03-31 
      
                                                     
      service revenues and sales
    624,900,000 618,798,000 646,943,000 639,993,000 606,181,000 595,880,000 589,233,000 585,912,000 564,532,000 553,816,000 560,157,000 546,654,000 526,472,000 531,288,000 530,549,000 540,978,000 538,667,000 532,256,000 527,360,000 533,289,000 528,297,000 502,199,000 515,798,000 522,324,000 480,613,000 473,584,000 439,176,000 415,059,000 278,739,000 386,226,000 381,921,000 376,652,000 358,389,000 360,182,000 358,300,000 340,886,000 357,198,000 366,641,000 354,353,000 354,170,000 341,439,000 333,360,000 330,918,000 320,451,000 314,995,000 308,813,000 296,794,000 288,312,000 285,268,000 
      yoy
    3.09% 3.85% 9.79% 9.23% 7.38% 7.60% 5.19% 7.18% 7.23% 4.24% 5.58% 1.05% -2.26% -0.18% 0.60% 1.44% 1.96% 5.99% 2.24% 2.10% 9.92% 6.04% 17.45% 25.84% 72.42% 22.62% 14.99% 10.20% -22.22% 7.23% 6.59% 10.49% 0.33% -1.76% 1.11% -3.75% 4.62% 9.98% 7.08% 10.52% 8.40% 7.95% 11.50% 11.15% 10.42%     
      qoq
    0.99% -4.35% 1.09% 5.58% 1.73% 1.13% 0.57% 3.79% 1.93% -1.13% 2.47% 3.83% -0.91% 0.14% -1.93% 0.43% 1.20% 0.93% -1.11% 0.94% 5.20% -2.64% -1.25% 8.68% 1.48% 7.83% 5.81% 48.91% -27.83% 1.13% 1.40% 5.10% -0.50% 0.53% 5.11% -4.57% -2.58% 3.47% 0.05% 3.73% 2.42% 0.74% 3.27% 1.73% 2.00% 4.05% 2.94% 1.07%  
      cost of services provided and goods sold
    427,993,000 434,105,000 430,530,000 405,875,000 396,187,000 389,750,000 385,127,000 358,346,000 362,358,000 374,193,000 370,705,000 349,570,000 346,934,000 336,821,000 336,552,000 336,328,000 342,164,000 350,493,000 340,473,000 335,049,000 339,240,000 352,163,000 351,745,000 347,355,000 328,183,000 323,637,000 304,536,000 285,852,000 218,694,000 272,089,000 270,663,000 268,885,000 256,445,000 257,007,000 257,819,000 243,184,000 255,359,000 264,307,000 256,610,000 257,368,000 245,063,000 239,597,000 237,458,000 227,915,000 223,702,000 219,137,000 208,888,000   
      selling, general and administrative expenses
    105,775,000 100,323,000 105,587,000 104,251,000 101,981,000 102,255,000 115,873,000 100,436,000 99,602,000 94,987,000 100,095,000 96,928,000 83,992,000 87,853,000 89,954,000 92,073,000 89,217,000 93,838,000 91,599,000 86,805,000 88,317,000 84,513,000 70,583,000 83,291,000 76,836,000 71,556,000 69,000,000 68,654,000 22,638,000 55,197,000 57,994,000 58,588,000 53,566,000 53,649,000 55,671,000 48,870,000 53,107,000 55,560,000 52,955,000 49,770,000 47,618,000 50,424,000 55,654,000 48,200,000 49,956,000 48,538,000 48,148,000 44,022,000 42,727,000 
      depreciation
    13,664,000 13,689,000 13,445,000 13,263,000 13,147,000 13,167,000 13,287,000 13,024,000 12,858,000 12,634,000 12,286,000 12,096,000 12,154,000 12,714,000 12,138,000 11,840,000 11,844,000 13,612,000 11,715,000 11,835,000 11,714,000 11,659,000 11,388,000 11,126,000 10,147,000 9,887,000 9,267,000 8,833,000 4,814,000 8,075,000 8,082,000 8,032,000 7,450,000 7,272,000 7,149,000 6,971,000 6,899,000 6,795,000 6,557,000 6,380,000 6,313,000 6,358,000 6,288,000 6,385,000 6,194,000 5,469,000 5,361,000 5,441,000 5,438,000 
      amortization
    2,570,000 2,571,000 2,572,000 2,568,000 2,550,000 2,546,000 2,521,000 2,515,000 2,521,000 2,514,000 2,513,000 2,512,000 2,520,000 2,520,000 2,518,000 2,510,000 2,510,000 2,510,000 2,510,000 2,511,000 2,511,000 2,488,000 2,477,000 2,969,000 441,000 406,000 27,000 32,000 14,000 737,000 582,000 576,000 717,000 735,000 1,009,000 1,190,000 1,181,000 1,127,000 1,135,000 1,127,000 1,134,000 1,139,000 970,000 1,196,000 1,287,000 1,224,000 1,611,000 1,494,000 1,450,000 
      other operating expense
    148,000 26,000 51,000 72,000 159,000  92,000    1,739,000                                       
      total costs and expenses
    550,150,000 550,714,000 552,185,000 526,115,000 514,024,000 507,755,000 516,900,000 474,518,000 477,682,000 484,310,000 487,338,000 465,327,000 445,615,000 439,350,000 441,175,000 442,949,000 445,798,000 460,557,000 446,919,000 390,040,000 453,989,000 409,439,000 436,435,000 444,872,000 415,685,000 408,056,000 382,779,000 454,007,000 250,651,000 336,098,000 337,321,000 336,081,000 318,178,000 318,663,000 321,648,000 311,676,000 331,306,000 327,789,000 318,383,000 314,645,000 300,128,000 297,518,000 300,370,000 283,696,000 281,139,000 274,368,000 264,008,000 253,403,000 255,427,000 
      income from operations
    74,750,000 68,084,000 94,758,000 113,878,000 92,157,000 88,125,000 72,333,000 111,394,000 86,850,000 69,506,000 72,819,000 81,327,000 80,857,000 91,938,000 89,374,000 98,029,000 92,869,000 71,699,000 80,441,000 143,249,000 74,308,000 92,760,000 79,363,000 77,452,000 64,928,000 65,528,000 56,397,000   50,128,000 44,600,000 40,571,000 40,211,000 41,519,000 36,652,000 29,210,000 25,892,000 38,852,000 35,970,000 39,525,000 41,311,000 35,842,000 30,548,000 36,755,000 33,856,000 34,445,000 32,786,000 34,909,000 29,841,000 
      yoy
    -18.89% -22.74% 31.00% 2.23% 6.11% 26.79% -0.67% 36.97% 7.41% -24.40% -18.52% -17.04% -12.93% 28.23% 11.11% -31.57% 24.98% -22.70% 1.36% 84.95% 14.45% 41.56% 40.72%   30.72% 26.45%   20.74% 21.69% 38.89% 55.30% 6.86% 1.90% -26.10% -37.32% 8.40% 17.75% 7.54% 22.02% 4.06% -6.83% 5.29% 13.45%     
      qoq
    9.79% -28.15% -16.79% 23.57% 4.58% 21.83% -35.07% 28.26% 24.95% -4.55% -10.46% 0.58% -12.05% 2.87% -8.83% 5.56% 29.53% -10.87% -43.85% 92.78% -19.89% 16.88% 2.47% 19.29% -0.92% 16.19%    12.39% 9.93% 0.90% -3.15% 13.28% 25.48% 12.81% -33.36% 8.01% -8.99% -4.32% 15.26% 17.33% -16.89% 8.56% -1.71% 5.06% -6.08% 16.98%  
      operating margin %
    11.96% 11.00% 14.65% 17.79% 15.20% 14.79% 12.28% 19.01% 15.38% 12.55% 13.00% 14.88% 15.36% 17.30% 16.85% 18.12% 17.24% 13.47% 15.25% 26.86% 14.07% 18.47% 15.39% 14.83% 13.51% 13.84% 12.84% 0% 0% 12.98% 11.68% 10.77% 11.22% 11.53% 10.23% 8.57% 7.25% 10.60% 10.15% 11.16% 12.10% 10.75% 9.23% 11.47% 10.75% 11.15% 11.05% 12.11% 10.46% 
      interest expense
    -457,000 -443,000 -329,000 -499,000 -427,000 -429,000 -425,000 -342,000 -444,000 -771,000 -1,551,000 -1,601,000 -1,271,000 -902,000 -810,000 -525,000 -583,000 -379,000 -381,000 -350,000 -379,000 -651,000 -975,000 -1,133,000 -1,041,000 -1,237,000 -1,207,000 -1,121,000 -59,000 -908,000 -969,000 -969,000 -980,000 -2,429,000 -3,815,000 -3,500,000 -3,697,000 -4,094,000 -3,743,000 -3,672,000 -3,555,000 -3,461,000 -3,244,000 -2,995,000 -2,999,000 -2,952,000 -2,853,000 -1,570,000 -1,597,000 
      other income - net
    9,251,000 3,474,000 1,245,000 7,002,000 9,299,000 6,132,000     -103,000     2,630,250 3,134,000   1,430,750 7,675,000   1,372,000 3,036,000 13,000 1,018,000    536,000 563,000 705,000 756,000 816,000  1,696,000 1,706,000    714,000        
      income before income taxes
    83,544,000 71,115,000 95,674,000 120,123,000 101,029,000 93,828,000 84,485,000 115,593,000 93,265,000 70,344,000 71,165,000 82,400,000 76,471,000 86,106,000 84,702,000 96,127,000 95,420,000 75,105,000 83,662,000 145,841,000 81,604,000 99,623,000 68,922,000 79,595,000 66,923,000 64,304,000 56,208,000   46,865,000 44,167,000 40,165,000 39,936,000 39,846,000 33,653,000 25,620,000 23,891,000 36,464,000 34,067,000 34,883,000 35,821,000 33,095,000 29,406,000 33,982,000 30,867,000 31,679,000 31,666,000 31,431,000 27,055,000 
      income taxes
    -19,307,000 -18,622,000 -23,917,000 -29,804,000 -25,253,000 -22,941,000 -19,468,000 -25,540,000 -18,307,000 -16,967,000 -17,044,000 -20,274,000 -19,598,000 -19,650,000 -20,533,000 -21,502,000 -23,417,000 -18,583,000 -18,262,000 -32,089,000 -13,882,000 -17,522,000 -13,031,000 -14,015,000 -7,976,000 -13,575,000 -11,212,000 16,760,000 -11,444,000 -18,032,000 -17,192,000 -15,628,000 -15,351,000 -15,483,000 -13,079,000 -8,188,000 -9,283,000 -14,186,000 -13,222,000 -13,609,000 -13,934,000 -12,809,000 -11,305,000 -12,994,000 -12,012,000 -12,321,000 -12,456,000 -13,483,000 -10,235,000 
      net income
    64,237,000 52,493,000 71,757,000 90,319,000 75,776,000 70,887,000 65,017,000 90,053,000 74,958,000 53,377,000 54,121,000 62,126,000 56,873,000 66,456,000 64,169,000 74,625,000 72,003,000 56,522,000 65,400,000 113,752,000 67,722,000 82,101,000 55,891,000 65,580,000 58,947,000 50,729,000 44,996,000  1.48 28,833,000 26,975,000 24,537,000 24,585,000 24,363,000 20,574,000 17,432,000 14,608,000 22,278,000 20,845,000 21,274,000 21,887,000 20,286,000 18,101,000 20,988,000 18,855,000 19,358,000 19,210,000 17,948,000 16,820,000 
      yoy
    -15.23% -25.95% 10.37% 0.30% 1.09% 32.80% 20.13% 44.95% 31.80% -19.68% -15.66% -16.75% -21.01% 17.58% -1.88% -34.40% 6.32% -31.16% 17.01% 73.46% 14.89% 61.84% 24.21%  3982905305.41% 75.94% 66.81%  -100.00% 18.35% 31.11% 40.76% 68.30% 9.36% -1.30% -18.06% -33.26% 9.82% 15.16% 1.36% 16.08% 4.79% -5.77% 16.94% 12.10%     
      qoq
    22.37% -26.85% -20.55% 19.19% 6.90% 9.03% -27.80% 20.14% 40.43% -1.37% -12.89% 9.24% -14.42% 3.56% -14.01% 3.64% 27.39% -13.57% -42.51% 67.97% -17.51% 46.89% -14.77% 11.25% 16.20% 12.74%   -100.00% 6.89% 9.94% -0.20% 0.91% 18.42% 18.02% 19.33% -34.43% 6.87% -2.02% -2.80% 7.89% 12.07% -13.76% 11.31% -2.60% 0.77% 7.03% 6.71%  
      net income margin %
    10.28% 8.48% 11.09% 14.11% 12.50% 11.90% 11.03% 15.37% 13.28% 9.64% 9.66% 11.36% 10.80% 12.51% 12.09% 13.79% 13.37% 10.62% 12.40% 21.33% 12.82% 16.35% 10.84% 12.56% 12.26% 10.71% 10.25% 0% 0.00% 7.47% 7.06% 6.51% 6.86% 6.76% 5.74% 5.11% 4.09% 6.08% 5.88% 6.01% 6.41% 6.09% 5.47% 6.55% 5.99% 6.27% 6.47% 6.23% 5.90% 
      earnings per share:
                                                     
      average number of shares outstanding
    14,394 14,591 14,622 -58 15,025 15,097 15,121 16 15,075 15,058 14,966 -6 14,888 14,932 14,986 -137 15,587 15,829 16,010 15,940 15,914 15,991 17 15,970 15,928 16,100 16,010 16,831 16,865 16,880 16,914 17,039 17,236 17,510 18,184 18,606 18,522 18,960 18,998 20,674 21,115 21,055 22,597 22,644 22,593 22,461  23,873 
      diluted earnings per share:
                                                     
      cash dividends per share
    0.6 0.5 0.5 0.325 0.5 0.4 0.4 0.29 0.4 0.38 0.38 0.275 0.38 0.36 0.36 0.26 0.36 0.34 0.34 0.245 0.34 0.32 0.32 0.23 0.32 0.3 0.28 0.26  0.24 0.22 0.22 0.22 0.2 0.2 0.2 0.18 0.18 0.18 0.16 0.16 0.14 0.14 0.14 0.12 0.12 0.12 0.06 0.06 
      see accompanying notes to unaudited consolidated financial statements.
                                                     
      other operating expense/
         37,000  516,000 343,000 -18,000  -132,500 15,000                                     
      other income/(expense) - net
          12,577,000 2,091,250 6,859,000         3,785,000 3,602,000         1,653,000  -2,355,000      -90,000   1,840,000 -970,000 -1,935,000         
      other income/(income) - net
             1,609,000                                        
      other (expense)/income - net
               -2,976,750 -3,115,000 -4,930,000 -3,862,000       7,514,000 -9,466,000                           
      other operating (income)/expense
                 -558,000                                    
      other operating expenses
                  13,000    622,000    242,000 131,000 78,000   90,636,000 4,491,000       11,461,000 14,760,000  1,126,000           
      other operating expenses/
                   197,250 63,000 104,000        2,570,000 -51,000                       
      other operating (income)/expenses
                       -7,233,750 12,207,000 -41,384,000                            
      income/(loss) from operations
                               -38,948,000 28,088,000                     
      income/(loss) before income taxes
                               -38,416,000                      
      net income/
                               -21,656,000 18,550,000                     
      earnings/(loss) per share
                                                     
      diluted earnings/(loss) per share
                                                     
      sg&a expenses before market value adjustments of deferred compensation
                                                     
      plans, long-term incentive compensation, and oig investigation expenses
                                117,708,000                     
      long-term incentive compensation
                                258,000                     
      expenses related to oig investigation
                                3,506,000                     
      impact of market value adjustments related to assets held in deferred
                                                     
      compensation trusts
                                201,000                     
      total sg&a expenses
                                121,673,000                     
      market value adjustment on assets held in
                                                     
      deferred compensation trusts
                                201,000                     
      loss on disposal of property and equipment
                                -90,000                     
      interest income - net
                                182,000                     
      other
                                6.2                     
      total other income/(expense) - net
                                293,000                     
      vitas
                                -3,479,000                     
      legal expenses of oig investigation
                                -2,165,000                     
      early retirement expenses
                                -2,840,000                     
      roto-rooter
                                2,198,000                     
      expenses related to litigation settlements
                                -27,000                     
      acquisition expenses
                                                     
      corporate
                                -506,000                     
      stock option expense
                                -3,061,000                     
      expenses of securities litigation
                                                     
      total
                                -8,257,000                     
      chemed corporation and subsidiary companies
                                                     
      consolidating statement of income
                                                     
      for the three months ended june 30, 2016
                                                     
      2016
                                                     
      intercompany interest income/
                                1,927,000                     
      other income/(expense)—net
                                38,000                     
      income/(expense) before income taxes
                                29,994,000                     
      pretax benefit/
                                                     
      expenses related to securities litigation
                                                     
      after-tax benefit/
                                                     
      for the three months ended june 30, 2015
                                                     
      2015
                                                     
      for the six months ended june 30, 2016
                                                     
      for the six months ended june 30, 2015
                                                     
      unaudited consolidating summary and reconciliation of adjusted ebitda
                                                     
      add/
                                                     
      ebitda
                                34,881,000                     
      intercompany interest expense/
                                -1,927,000                     
      interest income
                                -69,000                     
      amortization of stock awards
                                85,000                     
      advertising cost adjustment
                                                     
      adjusted ebitda
                                38,631,000                     
      stock award amortization
                                216,000                     
      reconciliation of adjusted net income
                                                     
      net income as reported
                                24,885,000                     
      add/(deduct) after-tax cost of:
                                                     
      expenses of oig investigation
                                722,000                     
      expenses related to securities settlements
                                -2,000                     
      adjusted net income
                                30,228,000                     
      diluted earnings per share as reported
                                                     
      adjusted diluted earnings per share
                                                     
      adjusted average number of shares outstanding
                                16,831                     
      operating statistics for vitas segment
                                                     
      operating statistics
                                2,016                     
      net revenue
                                                     
      homecare
                                219,280                     
      inpatient
                                24,489                     
      continuous care
                                34,970                     
      total before medicare cap allowance
                                278,739                     
      medicare cap allowance
                                                     
      net revenue as a percent of total before medicare cap allowances
                                                     
      average daily census
                                                     
      nursing home
                                3,015                     
      routine homecare
                                15,022                     
      total admissions
                                16,180                     
      total discharges
                                15,960                     
      average length of stay
                                84.2                     
      median length of stay
                                16                     
      adc by major diagnosis
                                                     
      cerebro
                                31.9                     
      neurological
                                21.3                     
      cancer
                                15.2                     
      cardio
                                17.6                     
      respiratory
                                7.8                     
      admissions by major diagnosis
                                                     
      direct patient care margins
                                                     
      homecare margin drivers
                                                     
      labor costs
                                56.29                     
      combined drug, hme and medical supplies
                                15.92                     
      inpatient margin drivers
                                                     
      continuous care margin drivers
                                                     
      bad debt expense as a percent of revenues
                                1.2                     
      accounts receivable -- days of revenue outstanding- excluding unapplied medicare payments
                                37.7                     
      accounts receivable -- days of revenue outstanding- including unapplied medicare payments
                                26.6                     
      february 2011 program
                                                     
      january 1 through january 31, 2016
                                                     
      february 1 through february 29, 2016
                                153,997                     
      march 1 through march 31, 2016
                                246,003                     
      first quarter total
                                400,000                     
      april 1 through april 30, 2016
                                                     
      may 31 through may 31, 2016
                                93,607                     
      june 1 through june 30, 2016
                                286,527                     
      second quarter total
                                380,134                     
      on march 14, 2016 our board of directors authorized an additional 100 million under the february 2011 repurchase program.
                                                     
      exhibit no.
                                                     
      31.1
                                                     
      31.2
                                                     
      31.3
                                                     
      32.1
                                                     
      32.2
                                                     
      32.3
                                                     
      101.ins
                                                     
      101.sch
                                                     
      101.cal
                                                     
      101.def
                                                     
      101.lab
                                                     
      101.pre
                                                     
      dated:
                                                     
      earnings per share
                                                     
      diluted earnings per share
                                                     
      see accompanying notes to unaudited financial statements.
                                                     
      other income
                                              2,102,000       
      other income--net
                                               222,000 10,000     
      other income/(expense)--net
                                                 186,000 1,733,000   
      continuing operations
                                                     
      other operating income
                                                     
      loss on extinguishment of debt
                                                     
      other (expense)/income--net
                                                   -1,908,000 -1,189,000 
      income from continuing operations
                                                   17,948,000  
      discontinued operations, net of income taxes
                                                     
      average number of share outstanding
                                                   22,503  
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.